These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 8492012)
1. [Relation between the outcome of IVF-ET and subtle rise in serum progesterone during the follicular phase stimulated with a combination of gonadotropin-releasing hormone analog and gonadotropin]. Sekijima A Nihon Sanka Fujinka Gakkai Zasshi; 1993 Mar; 45(3):249-55. PubMed ID: 8492012 [TBL] [Abstract][Full Text] [Related]
2. Increased progesterone/estradiol ratio on the day of HCG administration adversely affects success of in vitro fertilization-embryo transfer in patients stimulated with gonadotropin-releasing hormone agonist and recombinant follicle-stimulating hormone. Ou YC; Lan KC; Chang SY; Kung FT; Huang FJ Taiwan J Obstet Gynecol; 2008 Jun; 47(2):168-74. PubMed ID: 18603501 [TBL] [Abstract][Full Text] [Related]
3. Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of in vitro fertilization. Mio Y; Sekijima A; Iwabe T; Onohara Y; Harada T; Terakawa N Fertil Steril; 1992 Jul; 58(1):159-66. PubMed ID: 1623998 [TBL] [Abstract][Full Text] [Related]
4. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile]. Sudik R; Fliess FR; Kunkel S Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795 [TBL] [Abstract][Full Text] [Related]
5. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes. Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618 [TBL] [Abstract][Full Text] [Related]
6. Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin. Harada T; Yoshida S; Katagiri C; Takao N; Ikenari T; Toda T; Mio Y; Terakawa N Hum Reprod; 1995 May; 10(5):1060-4. PubMed ID: 7657741 [TBL] [Abstract][Full Text] [Related]
7. Falling FSH levels predict poor IVF pregnancy rates in patients whom the gonadotropins are withheld. Erman Akar M; Oktay K Arch Gynecol Obstet; 2009 Nov; 280(5):761-5. PubMed ID: 19255769 [TBL] [Abstract][Full Text] [Related]
8. The efficacy of a combination administration of gonadotropin-releasing hormone agonist and gonadotropins for controlled ovarian hyperstimulation in IVF program. Chang YS; Kim SH; Shin CJ; Kim JG; Moon SY; Lee JY Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):337-45. PubMed ID: 2129188 [TBL] [Abstract][Full Text] [Related]
9. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins]. Ellenbogen A; David H; Libal Y; Ballas S Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950 [TBL] [Abstract][Full Text] [Related]
10. Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort. Moffitt DV; Queenan JT; Shaw R; Muasher SJ Fertil Steril; 1997 Feb; 67(2):296-301. PubMed ID: 9022606 [TBL] [Abstract][Full Text] [Related]
11. [Impact of controlled ovarian hyperstimulation delayed, which occurs after functionally pituitary downregulation by depot GnRH agonist, on the outcome of in vitro fertilization and embryo transfer]. Ma QH; Li SW; Huang ZY; Han ZY; Qiu DS; Han DW Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):980-3. PubMed ID: 18095601 [TBL] [Abstract][Full Text] [Related]
12. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone. Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885 [TBL] [Abstract][Full Text] [Related]
13. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer. Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845 [TBL] [Abstract][Full Text] [Related]
14. Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles. Kiliçdag EB; Haydardedeoglu B; Cok T; Hacivelioglu SO; Bagis T Arch Gynecol Obstet; 2010 Apr; 281(4):747-52. PubMed ID: 19862542 [TBL] [Abstract][Full Text] [Related]
15. [The study on the relationship between luteal phase serum sex hormone levels and pregnancy outcome in in vitro fertilization embryo transfer cycle]. Tian X; Zhang L; Yang C Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):484-6. PubMed ID: 10806749 [TBL] [Abstract][Full Text] [Related]
16. Hormonal changes induced by short-term administration of gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development. Loumaye E; Vankrieken L; Depreester S; Psalti I; de Cooman S; Thomas K Fertil Steril; 1989 Jan; 51(1):105-11. PubMed ID: 2491990 [TBL] [Abstract][Full Text] [Related]
17. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. Silverberg KM; Burns WN; Olive DL; Riehl RM; Schenken RS J Clin Endocrinol Metab; 1991 Oct; 73(4):797-803. PubMed ID: 1909704 [TBL] [Abstract][Full Text] [Related]